Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Markers released top-line results today after previously reporting the trial succeeded.
How sure are we
Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.
Who reported it
[Claude] Both other reports cover the same trial result, a 42% cut in melanoma death or recurrence risk, with no conflicting facts.
3d ago[Claude] Report 2 covers the same release of the Moderna/Merck mRNA cancer vaccine trial results with the same 42% figure, adding a CEO reaction, which counts as the same event.
3d agoScore bands
What moves the score
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
Very high · How we score this